Medical Properties Trust, Inc.

NYSE:MPW Lagerbericht

Marktkapitalisierung: US$2.5b

Medical Properties Trust Zukünftiges Wachstum

Future Kriterienprüfungen 4/6

Medical Properties Trust wird ein jährliches Gewinn- und Umsatzwachstum von 112.3% bzw. 9.1% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 117.3% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 2.2% betragen.

Wichtige Informationen

112.3%

Wachstumsrate der Gewinne

117.3%

EPS-Wachstumsrate

Health Care REITs Gewinnwachstum22.9%
Wachstumsrate der Einnahmen9.1%
Zukünftige Eigenkapitalrendite2.2%
Analystenabdeckung

Good

Zuletzt aktualisiert14 Nov 2024

Jüngste Aktualisierungen zum künftigen Wachstum

Recent updates

Medical Properties Trust: Investors Should Be Worried About Liquidity Issues Ahead

Nov 14

Medical Properties Trust: Buy The Dip At A 50% Discount To Book Value

Nov 08

Medical Properties Trust Q3 Preview: Rare Insider Buy Indicates Improving Sentiment

Oct 29

Medical Properties Trust: Why Basket Making Is Important

Oct 21

My Biggest Loser List (Part 1): Medical Properties Trust (Rating Downgrade)

Oct 12

Medical Properties Trust Bulls Vs. 40%+ Short Interests

Sep 27

Medical Properties Trust: The Path To Gains Is Clearer Than Ever

Sep 20

Medical Properties Trust Soars On Positive Steward News

Sep 12

Upgrading Medical Properties Trust On Possible Bullish Catalyst

Sep 06

Medical Properties Trust: Weak Fundamentals And Bearish Technicals Vs. Low Valuations

Aug 27

Medical Properties Trust: Cash Flow Concerns Persist

Aug 21

Medical Properties Trust Is A Steal At This Price (Upgrade)

Aug 14

Medical Properties Trust: Results Incoming

Aug 06

Medical Properties Trust: The Endgame Unfolds

Jul 19

Medical Properties Trust: Why I Think It Is Worth Having A Pop

Jul 03

Medical Properties Trust: The Market Paints A Bright Future - Ignore

Jun 26

Medical Properties Trust's Turnaround Is Here - Initiate Cautious Buy

Jun 16

Medical Properties Trust: Steward Bankruptcy Exposes Shorts To Squeeze, 11.2% Dividend Yield

Jun 10

Medical Properties Trust: Renewed Risks To The Dividend

Jun 02

Medical Properties Trust Stock: Mr. Market Is Underestimating This REIT

May 25

Medical Properties: Don't Worry About The Steward Bankruptcy

May 12

Medical Properties Trust: Don't Celebrate Too Early

May 05

Very Good News For Medical Properties Trust

Apr 25

Medical Properties Trust: A Key Level Is Now In Sight (Technical Analysis)

Apr 18

Medical Properties Trust: No High Rewards Without High Risks (Rating Upgrade)

Apr 11

Medical Properties Trust Q4: Wouldn't Touch This REIT With A 10-Foot Pole

Apr 04

Medical Properties Trust: Stock Price Is Not Going Anywhere

Mar 18

Medical Properties Trust: Downgrading On Another Red Flag

Mar 07

Medical Properties Trust: Don't Fall For This Bear Market Rally

Mar 01

Medical Properties Trust Q4: No Guidance Causes Uncertainties

Feb 21

Confessions Of A Medical Properties Trust Bagholder

Jan 29

Lessons From Medical Properties Trust Stock's Implosion

Jan 16

Medical Properties Trust: A Cautionary Tale On Reaching For Yield

Jan 08

Medical Properties Trust: My Biggest Loser In 2023 (Rating Downgrade)

Jan 02

Medical Properties Trust: Dead Money At Best, Better To Avoid

Dec 25

Medical Properties Trust: Holding Through Recovery Efforts

Dec 18

Medical Properties Trust: Pricey Valuation With Various Downside Risks

Dec 04

Sell Medical Properties Trust And Buy These 10%-Yielding Blue Chips Instead

Nov 22

Medical Properties Trust: Invest In 12% Yielding Debt Over Shares

Nov 13

Medical Properties Trust: The Future Looks Bleak

Nov 02

Medical Properties Trust Is Fighting For Its Life

Oct 26

Is Medical Properties Trust A Potential Takeover Target?

Oct 20

Medical Properties Trust: Why I Am Selling At The Lows And Downgrading To 'Strong Sell'

Oct 11

Medical Properties Trust: Sifting Through The Rubble

Oct 01

Medical Properties Trust: A Disaster Investors Should Have Seen Coming

Sep 17

Medical Properties Trust: The Safest Dividend Is Probably The One That's Just Been Cut (Upgrade)

Aug 29

Medical Properties Trust: The Bottom Is In

Aug 22

Medical Properties Trust: Dividend Cut Incoming (Downgrade)

Aug 16

Gewinn- und Umsatzwachstumsprognosen

NYSE:MPW - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (USD Millions)
DatumUmsatzGewinneFreier CashflowBargeld aus operativen TätigkeitenDurchschn. Anz. Analysten
12/31/2026988104N/AN/A6
12/31/2025973115N/AN/A6
12/31/2024995-1,836N/AN/A2
9/30/2024660-2,663304304N/A
6/30/2024731-1,745403403N/A
3/31/2024805-1,466444444N/A
12/31/2023886-558506506N/A
9/30/20231,417-35551551N/A
6/30/20231,46370607607N/A
3/31/20231,528302695695N/A
12/31/20221,584901739739N/A
9/30/20221,6121,247792792N/A
6/30/20221,6461,197790790N/A
3/31/20221,6201,122802802N/A
12/31/20211,573654812812N/A
9/30/20211,496558753753N/A
6/30/20211,433517694694N/A
3/31/20211,341512699699N/A
12/31/20201,270429618618N/A
9/30/20201,192449609609N/A
6/30/20201,084408585585N/A
3/31/2020984378514514N/A
12/31/2019870372494494N/A
9/30/2019794319477477N/A
6/30/2019765966451451N/A
3/31/2019775998441441N/A
12/31/20187991,013449449N/A
9/30/20188191,008441441N/A
6/30/2018796349N/A404N/A
3/31/2018757311N/A393N/A
12/31/2017715288N/A362N/A
9/30/2017655260N/A316N/A
6/30/2017606254N/A282N/A
3/31/2017566235N/A260N/A
12/31/2016541224N/A264N/A
9/30/2016517240N/A243N/A
6/30/2016505192N/A257N/A
3/31/2016479161N/A234N/A
12/31/2015445139N/A207N/A
9/30/201539595N/A187N/A
6/30/2015362101N/A188N/A
3/31/201533878N/A174N/A
12/31/201431550N/A150N/A
9/30/201430148N/A135N/A
6/30/201428045N/A135N/A
3/31/201426170N/A132N/A
12/31/201324688N/A141N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: MPW wird in den nächsten 3 Jahren voraussichtlich rentabel werden, was als schnelleres Wachstum als die Sparquote angesehen wird (2.6%).

Ertrag vs. Markt: MPW wird in den nächsten 3 Jahren voraussichtlich rentabel werden, was als überdurchschnittliches Marktwachstum angesehen wird.

Hohe Wachstumserträge: MPW wird voraussichtlich in den nächsten 3 Jahren rentabel werden.

Einnahmen vs. Markt: MPWDie Einnahmen des Unternehmens (9.1% pro Jahr) werden voraussichtlich schneller wachsen als der Markt US (9% pro Jahr).

Hohe Wachstumseinnahmen: MPWDie Einnahmen des Unternehmens (9.1% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: MPWDie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (2.2%).

Wachstumsunternehmen entdecken

7D

1Y

7D

1Y

7D

1Y